Analysis of the killer phenotype in commercial and clinical isolates of Saccharomyces cerevisiae

A tétel rövid nézete
dc.contributor.advisorPfliegler, Valter
dc.contributor.authorZaki, Omaima
dc.contributor.departmentDE--Természettudományi és Technológiai Kar--Biotechnológiai Intézethu_HU
dc.date.accessioned2021-11-15T09:42:08Z
dc.date.available2021-11-15T09:42:08Z
dc.date.created2021-11-12
dc.description.abstractSome strains of yeasts can develop killer phenotype derived from cytoplasmic dsRNA in a VLP in which viral toxin protein is secreted to kill sensitive yeasts of the same species. We aimed to investigate various commercial and clinical probiotic strains of S. boulardii reaction under the influence of killer toxin strains (K1 and K2), thus killer strains and no-killer strains were used as controls. Moreover, the linked gene CNVs among the strains for killer sensitivity can be determined and studied further.hu_HU
dc.description.correctorhbk
dc.description.courseBiochemical Engineering BSchu_HU
dc.description.degreeBSc/BAhu_HU
dc.format.extent39hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/324618
dc.language.isoenhu_HU
dc.subjectSaccharomyces cerevisiaehu_HU
dc.subjectkiller phenotype
dc.subjectcopy number variation
dc.subject.dspaceDEENK Témalista::Biológiai tudományokhu_HU
dc.titleAnalysis of the killer phenotype in commercial and clinical isolates of Saccharomyces cerevisiaehu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Science and Technology)